The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 26, 2024

Filed:

Feb. 28, 2018
Applicant:

Seagen Inc., Bothell, WA (US);

Inventors:

Andrew Waight, Bothell, WA (US);

Chris Leiske, Bothell, WA (US);

Travis Biechele, Bothell, WA (US);

Django Sussman, Bothell, WA (US);

Patrick Burke, Bothell, WA (US);

Jocelyn Leiske, Bothell, WA (US);

Assignee:

SEAGEN INC., Bothell, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); C07K 16/18 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6829 (2017.08); A61K 47/6851 (2017.08); A61K 47/6889 (2017.08); C07K 16/18 (2013.01); C07K 2317/524 (2013.01);
Abstract

The invention provides modified heavy chain constant regions including a cysteine at position 295 by EU numbering and optionally at position 239 by EU numbering. These cysteine residues provide sites for conjugation to a drug or label. When both cysteines are present in a normal heterodimeric antibody format, there are four such sites per molecule of antibody allowing a stoichiometry of one molecule of antibody to four of drug or label. Selection of the cysteine at position 295 with or without cysteine at position 239 is advantageous over cysteines at many other positions due to ease of expression, stability and cytotoxicity.


Find Patent Forward Citations

Loading…